z-logo
open-access-imgOpen Access
Allogeneic Hematopoietic Stem-Cell Transplantation in Myelofibrosis: Key Messages for Clinical Practice in the Era of Janus Kinase 1/2 Inhibitors
Author(s) -
Piyanuch Kongtim,
Uday Popat
Publication year - 2016
Publication title -
journal of oncology practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.555
H-Index - 60
eISSN - 1935-469X
pISSN - 1554-7477
DOI - 10.1200/jop.2016.014308
Subject(s) - medicine , myelofibrosis , hematopoietic stem cell transplantation , transplantation , janus , ruxolitinib , stem cell , janus kinase , key (lock) , hematopoietic cell , haematopoiesis , janus kinase 2 , clinical practice , hematopoietic stem cell , cancer research , bioinformatics , oncology , immunology , family medicine , microbiology and biotechnology , biology , computer security , computer science , bone marrow , programming language , receptor , cytokine

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom